Advertisement Caliper, Trinean enter DropSense platform agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Caliper, Trinean enter DropSense platform agreement

Caliper Life Sciences has signed a long-term agreement with Trinean, under which Caliper will distribute Trinean's DropSense platform under the trade name LabChip DS in North American markets.

The LabChip DS, an automated UV/Vis spectral analysis platform helps in analysing concentration levels of about 96 nucleic acid and protein samples within a few minutes.

Trinean CEO Marc Zabeau said the platform provides concentration analysis of 0.5 to 3.0 microlitre droplets of sample with significant time savings and automation benefits to researchers.

The LabChip DS is used to analyse concentration of extracted genomic DNA.